丽珠医药siRNA新药获批临床

健识局
24 Jun

近日,中国国家药监局药品审评中心官网公示,丽珠医药申报的1类新药YJH-012注射液获批临床,拟开发治疗痛风。痛风是一种由高尿酸血症引发的常见且复杂的关节炎类型疾病。尿酸主要由饮食摄入和体内分解的嘌呤化合物,经肝脏代谢产生。一旦血尿酸超过正常数值,进入高尿酸血症状态,尿酸钠晶体便会形成,并沉积于关节及周围软组织、肾组织和血管等部位,引发剧烈疼痛、慢性炎症甚至多器官损伤。据企业官网信息,YJH-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10